Literature DB >> 32402443

Aquaculture and by-products: Challenges and opportunities in the use of alternative protein sources and bioactive compounds.

María López-Pedrouso1, José M Lorenzo2, Jesús Cantalapiedra3, Carlos Zapata1, José M Franco4, Daniel Franco5.   

Abstract

There is a growing concern about chronic diseases such as obesity, diabetes, hypertension, hypercholesterolemia, cancer and cardiovascular diseases resulting from profound changes in the western lifestyle. Aquaculture by-products are generated in large quantities and they can be profitably recycled through their bioactive compounds used for health or food supplements. Improving waste utilization in the field of aquaculture is essential for a sustainable industry to prevent or minimize the environmental impact. In this sense fish by-products are a great source of protein and omega-3 polyunsaturated fatty acids which are particularly studied on Atlantic salmon or rainbow trout. Fish protein hydrolysate (FPH) obtained from chemical, enzymatical and microbial hydrolysis of processing by-products are being used as a source of amino acids and peptides with high digestibility, fast absorption and important biological activities. Omega-3 polyunsaturated fatty acids, eicosapentaenoic (EPA) and docosahexaenoic (DHA) from fish discards have been reported to decrease postprandial triacylglycerol levels, reduction of blood pressure, platelet aggregation and the inflammatory response. Crustacean by-products can also be used to produce chitosan with antioxidant and antimicrobial activity for food and pharmaceutical industries and carotenoids with important biological activity. Seaweeds are rich in bioactive compounds such as alginate, carrageenan, agar, carotenoids and polyphenols with different biological activities such as antioxidant, anticancer, antidiabetic, antimicrobial or anti-inflammatory activity. Finally, regarding harvest microalgae, during the past decades, they were mainly used in the healthy food market, with >75% of the annual microalgal biomass production, used for the manufacture of powders, tablets, capsules or pills. We will report and discuss the present and future role of aquaculture by-products as sources of biomolecules for the design and development of functional foods/beverages. This chapter will focus on the main bioactive compounds from aquaculture by-products as functional compounds in food and their applications in biomedicine for the prevention and treatment of diseases.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  By-products; Fish protein hydrolysate; Functional foods; Healthy foods; Microalgae bioactive compounds; Seaweed biomolecules

Mesh:

Substances:

Year:  2019        PMID: 32402443     DOI: 10.1016/bs.afnr.2019.11.001

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  5 in total

Review 1.  Finding Biomarkers in Antioxidant Molecular Mechanisms for Ensuring Food Safety of Bivalves Threatened by Marine Pollution.

Authors:  María López-Pedrouso; José M Lorenzo; Zulema Varela; J Ángel Fernández; Daniel Franco
Journal:  Antioxidants (Basel)       Date:  2022-02-11

Review 2.  Omega-3-Rich Oils from Marine Side Streams and Their Potential Application in Food.

Authors:  Mirian Pateiro; Rubén Domínguez; Theodoros Varzakas; Paulo E S Munekata; Elena Movilla Fierro; José M Lorenzo
Journal:  Mar Drugs       Date:  2021-04-21       Impact factor: 5.118

3.  Comprehensive lipidomic analysis of the lipids extracted from freshwater fish bones and crustacean shells.

Authors:  Shuang Lv; Suya Xie; Yunxia Liang; Long Xu; Liangbin Hu; Hongbo Li; Haizhen Mo
Journal:  Food Sci Nutr       Date:  2022-01-14       Impact factor: 2.863

Review 4.  Functional proteins through green refining of seafood side streams.

Authors:  Vazhiyil Venugopal; Abhilash Sasidharan
Journal:  Front Nutr       Date:  2022-08-25

5.  Collagen-Containing Fish Sidestream-Derived Protein Hydrolysates Support Skin Repair via Chemokine Induction.

Authors:  Ioanna Lapi; Ourania Kolliniati; Tone Aspevik; Eleftherios E Deiktakis; Konstantinos Axarlis; Maria G Daskalaki; Eirini Dermitzaki; Maria Tzardi; Sotirios C Kampranis; Zouhir El Marsni; Katerina C Kousoulaki; Christos Tsatsanis; Maria Venihaki
Journal:  Mar Drugs       Date:  2021-07-15       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.